Sentry Investment Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,203
Closed -$308K 300
2025
Q4
$308K Hold
3,203
0.2% 93
2025
Q3
$313K Sell
3,203
-867
-21% -$79.7K 0.21% 91
2025
Q2
$361K Hold
4,070
0.2% 111
2025
Q1
$338K Sell
4,070
-1,216
-23% -$109K 0.23% 96
2024
Q4
$422K Sell
5,286
-861
-14% -$74.5K 0.2% 111
2024
Q3
$553K Sell
6,147
-289
-4% -$24.3K 0.23% 96
2024
Q2
$507K Sell
6,436
-555
-8% -$45.5K 0.23% 99
2024
Q1
$609K Hold
6,991
0.24% 101
2023
Q4
$576K Sell
6,991
-751
-10% -$57.2K 0.25% 97
2023
Q3
$607K Sell
7,742
-1,669
-18% -$140K 0.29% 70
2023
Q2
$829K Buy
9,411
+641
+7% +$55.2K 0.31% 72
2023
Q1
$707K Buy
8,770
+2,344
+36% +$191K 0.29% 87
2022
Q4
$499K Sell
6,426
-2,737
-30% -$222K 0.22% 121
2022
Q3
$740K Hold
9,163
0.35% 61
2022
Q2
$822K Sell
9,163
-1,785
-16% -$181K 0.37% 59
2022
Q1
$1.22M Sell
10,948
-1,841
-14% -$194K 0.39% 57
2021
Q4
$1.32M Buy
12,789
+356
+3% +$41.2K 0.35% 67
2021
Q3
$1.56M Sell
12,433
-1,816
-13% -$235K 0.45% 41
2021
Q2
$1.77M Buy
14,249
+380
+3% +$47.7K 0.45% 49
2021
Q1
$1.64M Sell
13,869
-71,538
-84% -$8.38M 0.45% 45
2020
Q4
$10M Sell
85,407
-595
-0.7% -$65.5K 0.5% 42
2020
Q3
$8.94M Buy
86,002
+8,387
+11% +$842K 0.5% 46
2020
Q2
$7.12M Sell
77,615
-7,944
-9% -$762K 0.43% 51
2020
Q1
$7.72M Buy
85,559
+1,555
+2% +$165K 0.57% 42
2019
Q4
$9.53M Hold
84,004
0.57% 34
2019
Q3
$9.13M Buy
84,004
+1,162
+1% +$121K 0.6% 34
2019
Q2
$8.07M Buy
82,842
+1,506
+2% +$138K 0.53% 39
2019
Q1
$7.41M Sell
81,336
-7,168
-8% -$642K 0.51% 46
2018
Q4
$8.05M Sell
88,504
-2,266
-2% -$212K 0.58% 40
2018
Q3
$8.93M Hold
90,770
0.54% 43
2018
Q2
$7.77M Sell
90,770
-9,950
-10% -$831K 0.51% 44
2018
Q1
$8.08M Sell
100,720
-6,416
-6% -$529K 0.49% 44
2017
Q4
$8.65M Sell
107,136
-3,231
-3% -$259K 0.47% 46
2017
Q3
$8.58M Sell
110,367
-72
-0.1% -$5.98K 0.32% 50
2017
Q2
$9.8M Buy
110,439
+1,081
+1% +$91.2K 0.39% 44
2017
Q1
$8.81M Sell
109,358
-2,536
-2% -$198K 0.36% 45
2016
Q4
$7.97M Sell
111,894
-67
-0.1% -$5.26K 0.33% 49
2016
Q3
$9.67M Buy
111,961
+2,239
+2% +$195K 0.42% 42
2016
Q2
$9.52M Sell
109,722
-33
-0% -$2.67K 0.42% 46
2016
Q1
$8.23M Hold
109,755
0.37% 49
2015
Q4
$8.44M Buy
109,755
+25,380
+30% +$1.91M 0.39% 48
2015
Q3
$5.65M Buy
84,375
+9,800
+13% +$722K 0.28% 70
2015
Q2
$5.53M Sell
74,575
-12,764
-15% -$975K 0.26% 74
2015
Q1
$6.81M Buy
87,339
+38,965
+81% +$2.95M 0.32% 60
2014
Q4
$3.49M Sell
48,374
-343
-0.7% -$23.8K 0.17% 106
2014
Q3
$3.02M Sell
48,717
-5,656
-10% -$360K 0.15% 105
2014
Q2
$3.47M Sell
54,373
-3,874
-7% -$235K 0.18% 95
2014
Q1
$3.58M Hold
58,247
0.19% 80
2013
Q4
$3.34M Sell
58,247
-1,400
-2% -$79.4K 0.18% 94
2013
Q3
$3.18M Buy
59,647
+22,310
+60% +$1.2M 0.19% 86
2013
Q2
$1.92M Buy
+37,337
New +$1.85M 0.11% 94

Other funds holding MDT

Sentry Investment Management's MDT Position: Q1 2026 in Review

Sentry Investment Management sold out of Medtronic (MDT) in Q1 2026, closing a stake of 3,203 shares — an estimated $308K sold.

Sentry Investment Management first reported a position in MDT in Q2 2013 and held it in 51 quarters. The position peaked at $10M in Q4 2020. 2,244 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Sentry Investment Management reported no remaining Medtronic position as of Q1 2026 after selling out during the quarter.
  • Sentry Investment Management sold 3,203 Medtronic shares in Q1 2026, an estimated $308K.
  • Sentry Investment Management first reported a position in Medtronic in Q2 2013 and held it in 51 quarters.
  • Sentry Investment Management's Medtronic position peaked at $10M in Q4 2020.
  • 2,244 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Sentry Investment Management's 13F filing for Q1 2026, filed 8 May 2026.